IGHE and primary hypertrophic osteoarthropathy: As a result, the prevalence of sera IgE sensitized to PHO among those with allergy decreased from 11% to 2.7% in 2010, that is, after 3 years without PHO available OTC or by prescription [6] but, still for some time, at the individual's "drug store" at home.